Xadago 27505-0111
Generic: Safinamide Mesylate
Product NDC
27505-0111- Manufacturer
- Mdd Us Operations Llc, A Subsidiary Of Supernus Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 8, 2017
- Listing Expires
- December 31, 2026
- Application
- NDA207145
Need to source Xadago? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Safinamide Mesylate | 100 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Monoamine Oxidase Type B Inhibitor [EPC]Monoamine Oxidase-B Inhibitors [MoA]
Packaging Options(3)
1 BLISTER PACK in 1 CARTON (27505-111-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (27505-111-30) / 30 TABLET, FILM COATED in 1 BOTTLE
1 BOTTLE in 1 CARTON (27505-111-90) / 90 TABLET, FILM COATED in 1 BOTTLE